SCHEMBL9998101

SCHEMBL9998101

CC/C(=C\c1ccccc1F)C(OC(C)=O)OC(C)=O

nearest known ligand 0.48

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TRPA1 O75762 1/20 0.48
CYP1A2 P05177 3/20 0.44
CYP2C19 P33261 2/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2C9 P11712 1/20 0.44
HIF1A Q16665 1/20 0.44
RAB9A P51151 4/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
ALDH1A1 P00352 3/20 0.41
NPC1 O15118 3/20 0.41
GAA P10253 1/20 0.39
LMNA P02545 2/20 0.37
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
MAPT P10636 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
MAOB P27338 1/20 0.36
NFE2L2 Q16236 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9998103 1.00 TRPA1 (0.48) TRPA1CYP1A2CYP2C19CYP3A4CYP2C9
SCHEMBL9998598 0.89 CYP1A2 (0.43) TRPA1CYP1A2CYP2C19CYP3A4CYP2C9
SCHEMBL9998597 0.89 CYP1A2 (0.43) TRPA1CYP1A2CYP2C19CYP3A4CYP2C9
SCHEMBL9997608 0.85 CYP2C19 (0.45) TRPA1CYP1A2CYP2C19CYP3A4CYP2C9
SCHEMBL9997610 0.85 CYP2C19 (0.45) TRPA1CYP1A2CYP2C19CYP3A4CYP2C9
SCHEMBL9997859 0.84 KCNH2 (0.34) CYP3A4ALDH1A1LMNAMEN1KMT2A
SCHEMBL9997822 0.84 ALDH1A1 (0.38) CYP3A4SMN1; SMN2ALDH1A1GAALMNA
SCHEMBL9997823 0.84 ALDH1A1 (0.38) CYP3A4SMN1; SMN2ALDH1A1GAALMNA
SCHEMBL9997860 0.84 KCNH2 (0.34) CYP3A4ALDH1A1LMNAMEN1KMT2A
SCHEMBL9997475 0.83 CYP1A2 (0.48) TRPA1CYP1A2CYP2C19CYP3A4CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8558012-B2 2-fluoro-1,3-benzodithiol 1,1,3,3-tetraoxide derivative, production method thereof, and production method of monofluoromethyl group-containing compound using the same NAGOYA INSTITUTE OF TECHNOLOGY (JP) 2013-10-15 US disclosed
US-20110319637-A1 2-FLUORO-1,3-BENZODITHIOL 1,1,3,3-TETRAOXIDE DERIVATIVE, PRODUCTION METHOD THEREOF, AND PRODUCTION METHOD OF MONOFLUOROMETHYL GROUP-CONTAINING COMPOUND USING THE SAME NAGOYA INSTITUTE OF TECHNOLOGY (JP) 2011-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110319637-A1 2-FLUORO-1,3-BENZODITHIOL 1,1,3,3-TETRAOXIDE DERIVATIVE, PRODUCTION METHOD THEREOF, AND PRODUCTION METHOD OF MONOFLUOROMETHYL GROUP-CONTAINING COMPOUND USING THE SAME CBR1, CYP1B1, CYP2F1 TRPA1 1040/4885CYP1A2 19/4885CYP2C19 85/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.